4//SEC Filing
Yi Kathy 4
Accession 0000899243-21-005091
CIK 0001805387other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:42 PM ET
Size
5.5 KB
Accession
0000899243-21-005091
Insider Transaction Report
Form 4
Yi Kathy
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-03+216,718→ 216,718 totalExercise: $12.70Exp: 2031-02-03→ Common Stock (216,718 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on February 3, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001697802
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:42 PM ET
- Size
- 5.5 KB